Research progress of biomarkers in early detection of chemotherapy-induced cardiotoxicity

被引:0
作者
Wanli Gai
Jian An
Zhixin Wang
Xuebin Han
Jianhui Geng
Yunliang Liang
Yanqing Guo
机构
[1] Shanxi Cardiovascular Hospital,Department of Cardiology
[2] First Hospital of Shanxi Medical University,Department of Cardiovascular Medicine
来源
Heart Failure Reviews | 2021年 / 26卷
关键词
Biomarker; Chemotherapy; Cardiotoxicity;
D O I
暂无
中图分类号
学科分类号
摘要
With the advances of drug therapy, the prognosis of cancer patients has seen remarkable improvements, and cancer-related mortality has decreased significantly. However, the followed drug-related cardiotoxicity becomes a serious threat to patients’ living quality and survival rate. Cardiovascular toxicity associated with some chemotherapy drugs is reversible and dose-dependent. If early identification is possible, early cardiovascular protection measures or adjustment of chemotherapy regimens can be taken to improve the prognosis of patients. Therefore, early prevention and monitoring of chemotherapy-related cardiotoxicity are critical for cancer patients and survivors. Among them, biomarkers are an important method for the early identification of myocardial injury.
引用
收藏
页码:1195 / 1201
页数:6
相关论文
共 258 条
  • [21] Agler DA(2017)Arginine-nitric oxide metabolites and cardiac dysfunction in patients with breast cancer[J] J Am Coll Cardiol 70 152-308
  • [22] Badano LP(2017)Biomarkers of aging associated with past treatments in breast cancer survivors[J] NPJ Breast Cancer 3 50-849
  • [23] Banchs J(2011)Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib[J] Clin Cancer Res 17 3490-3387
  • [24] Cardinale D(2009)Human heart-type fatty acid-binding protein as an early diagnostic marker of doxorubicin cardiac toxicity[J] Hematol Rev 1 543-933
  • [25] Carver J(1997)Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I.[J] N Engl J Med 337 1648-235
  • [26] Cerqueira M(2010)Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention[J] J Natl Cancer Inst 102 14-945
  • [27] DeCara J(2014)Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy[J] Eur J Heart Fail 16 300-14
  • [28] Edvardsen T(2006)Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine[J] Heart 92 843-1488
  • [29] Flamm SD(2016)Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients.[J] Tumor Biol 37 3379-1102
  • [30] Force T(2013)Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia[J] Int J Clin Oncol 18 927-243